Tag: RBM

Checklists for RBM Documentation Before Major Health Authority Meetings Checklists for RBM Documentation Before Major Health Authority Meetings Introduction to Risk-Based Monitoring (RBM) in Clinical Trials Risk-Based Monitoring (RBM) is a strategic approach utilized during the conduct of clinical trials, particularly in phase 3b clinical trials. This method emphasizes the prioritization of critical data for…

Read More “Checklists for RBM Documentation Before Major Health Authority Meetings” »

Case Studies: Regulatory Feedback on RBM Submissions in US, EU and UK In the realm of clinical research, the integration of a Risk-Based Monitoring (RBM) approach has been increasingly emphasized by regulatory authorities such as the FDA, EMA, and MHRA. This article aims to provide a comprehensive overview of the regulatory feedback on RBM submissions…

Read More “Case Studies: Regulatory Feedback on RBM Submissions in US, EU and UK” »

Balancing Transparency and Flexibility in RBM Documentation Balancing Transparency and Flexibility in RBM Documentation The integration of Risk-Based Monitoring (RBM) in clinical trials has revolutionized the way data is collected, analyzed, and utilized throughout the clinical research process. This transition towards a more risk-based approach raises several documentation-related challenges that must be effectively addressed to…

Read More “Balancing Transparency and Flexibility in RBM Documentation” »

Responding to Regulatory Questions About RBM and Data Reliability Responding to Regulatory Questions About RBM and Data Reliability Regulatory agencies across the globe, including the FDA, EMA, and MHRA, are increasingly focusing on the reliability of data generated during clinical trials. The introduction of Risk-Based Monitoring (RBM) strategies has raised numerous questions regarding data integrity,…

Read More “Responding to Regulatory Questions About RBM and Data Reliability” »

TMF Artifacts That Show RBM Was Planned, Executed and Adjusted In the realm of clinical research, the robust documentation of clinical trials is paramount, not only for regulatory compliance but also for the enhancement of data quality and operational efficiency. Risk-Based Monitoring (RBM) is a strategy that optimizes the oversight processes of clinical trials, focusing…

Read More “TMF Artifacts That Show RBM Was Planned, Executed and Adjusted” »

Aligning RBM Documentation Across Protocol, SAP, Monitoring Plan and QMS Aligning RBM Documentation Across Protocol, SAP, Monitoring Plan and QMS Introduction to Risk-Based Monitoring in Clinical Trials Risk-Based Monitoring (RBM) has emerged as a critical approach to enhance the efficiency and effectiveness of clinical trials. With increasing complexity and regulatory scrutiny, clinical trial investigators find…

Read More “Aligning RBM Documentation Across Protocol, SAP, Monitoring Plan and QMS” »

Evidence Packages to Demonstrate RBM Execution and Oversight The evolution of clinical research demands innovative methodologies, particularly around risk-based monitoring (RBM) and remote oversight. Regulatory agencies such as the FDA, EMA, and MHRA are increasingly emphasizing the importance of robust documentation to support these practices. This article provides a comprehensive step-by-step guide aimed at clinical…

Read More “Evidence Packages to Demonstrate RBM Execution and Oversight” »

Regulatory Expectations for Describing RACT, CtQ, KRIs and QTLs Regulatory Expectations for Describing RACT, CtQ, KRIs and QTLs Clinical trials are essential to the development of effective medical interventions. Their management requires adherence to strict regulations, particularly regarding documentation and monitoring of risk. As the industry evolves towards Risk-Based Monitoring (RBM), appropriate documentation related to…

Read More “Regulatory Expectations for Describing RACT, CtQ, KRIs and QTLs” »

Preparing RBM Methodology White Papers for Complex Programs Preparing RBM Methodology White Papers for Complex Programs Understanding Risk-Based Monitoring in Clinical Trials Risk-Based Monitoring (RBM) is an innovative approach to clinical trial management designed to improve the oversight of clinical research while ensuring compliance with regulatory standards. The methodology shifts the focus from traditional monitoring…

Read More “Preparing RBM Methodology White Papers for Complex Programs” »

Documenting RBM Strategy for Health Authorities: What to Include and Why In the context of clinical trials, especially those focused on ovarian cancer, ensuring compliance with regulatory requirements is a multifaceted process. Among the various strategies employed to enhance the efficiency of clinical trials, Risk-Based Monitoring (RBM) has emerged as a noteworthy approach. This step-by-step…

Read More “Documenting RBM Strategy for Health Authorities: What to Include and Why” »